{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:09Z","timestamp":1786118889803,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.pain.2008.07.013","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T04:47:22Z","timestamp":1226724442000},"page":"19-24","source":"Crossref","is-referenced-by-count":47,"title":["Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies \u2606"],"prefix":"10.1097","volume":"141","author":[{"given":"T. W.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Backonja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Leibensperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Froman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Polydefkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210112","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1377\/hlthaff.25.2.420","article-title":"Estimating the cost of new drug development: is it really 802 million dollars?","volume":"25","author":"Adams","year":"2006","journal-title":"Health Aff Project Hope"},{"key":"R2-8-20210112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"R3-8-20210112","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"R4-8-20210112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal.","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"R5-8-20210112","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy.","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"R6-8-20210112","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.410440111","article-title":"Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases.","volume":"44","author":"Holland","year":"1998","journal-title":"Ann Neurol"},{"key":"R7-8-20210112","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.48.3.708","article-title":"Intraepidermal nerve fiber density in patients with painful sensory neuropathy.","volume":"48","author":"Holland","year":"1997","journal-title":"Neurology"},{"key":"R8-8-20210112","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.NMD.0000061144.16176.38","article-title":"Placebo response and antidepressant clinical trial outcome.","volume":"191","author":"Khan","year":"2003","journal-title":"J Nerv Ment Dis"},{"key":"R9-8-20210112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mus.10181","article-title":"Small-fiber neuropathy.","volume":"26","author":"Lacomis","year":"2002","journal-title":"Muscle Nerve"},{"key":"R10-8-20210112","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"R11-8-20210112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pain.2005.10.007","article-title":"Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy.","volume":"120","author":"Odrcich","year":"2006","journal-title":"Pain"},{"key":"R12-8-20210112","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial see comments.","volume":"280","author":"Rowbotham","year":"1998","journal-title":"Jama"},{"key":"R13-8-20210112","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data.","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"key":"R14-8-20210112","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance.","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"key":"R15-8-20210112","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research.","volume":"271","author":"Turner","year":"1994","journal-title":"Jama"},{"key":"R16-8-20210112","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0304-3959(02)00205-1","article-title":"3rd, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia.","volume":"99","author":"Vase","year":"2002","journal-title":"Pain"},{"key":"R17-8-20210112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.","volume":"128","author":"Vinik","year":"2007","journal-title":"Pain"},{"key":"R18-8-20210112","first-page":"217","article-title":"The association between psychopathology and placebo analgesia in patients with discogenic low back pain. Pain Med Malden, Mass.","volume":"7","author":"Wasan","year":"2006","journal-title":""},{"key":"R19-8-20210112","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200901000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:26Z","timestamp":1786036466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200901000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2008.07.013","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}